301188 力诺药包
2025/09 - 九个月2024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)3.2224.2434.4078.35613.050
总资产报酬率 ROA (%)2.0702.9323.4787.28910.991
投入资产回报率 ROIC (%)2.3953.2703.8138.10712.339

边际利润分析
销售毛利率 (%)21.17519.01017.43822.09325.043
营业利润率 (%)8.0336.6727.69415.44515.790
息税前利润/营业总收入 (%)10.4198.2088.19214.39816.033
净利润/营业总收入 (%)7.0576.1136.95814.19114.038

收益指标分析
经营活动净收益/利润总额(%)63.07984.37677.05585.15992.907
价值变动净收益/利润总额(%)13.75318.51819.25611.2233.693
营业外收支净额/利润总额(%)-0.061-0.932-0.109-0.189-0.056

偿债能力分析
流动比率 (X)2.7774.0887.0734.7735.373
速动比率 (X)1.8623.2796.0053.9304.751
资产负债率 (%)37.36334.03227.46112.72912.802
带息债务/全部投入资本 (%)22.56321.00219.9522.0222.385
股东权益/带息债务 (%)324.168359.905394.1364,801.7124,063.183
股东权益/负债合计 (%)167.647193.840264.157685.633681.110
利息保障倍数 (X)4.3585.13716.164-14.14663.534

营运能力分析
应收账款周转天数 (天)82.69665.40862.86864.70851.568
存货周转天数 (天)165.24198.15985.14179.73459.226